Post mortem MRI of cholinergic white matter pathways across neurodegenerative diseases
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71851 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Francisco J López-González und 9 weiteren Autor:innen. Beteiligte Einrichtung: Reina Sofia Alzheimer Center, CIEN Foundation, ISCIII, Madrid, Spain. Hauptthemen laut MEDLINE: White Matter, Magnetic Resonance Imaging, Alzheimer Disease, Neurodegenerative Diseases. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Next Generation funding UE/Mecanismo de Recuperación y Resiliencia, ISCIII, European Union's Horizon Europe research and innovation programme.
Abstract (Originalsprache)
INTRODUCTION Cholinergic white matter pathway (CWMP) degeneration is central in Alzheimer's disease (AD) and Lewy body disease (LBD). CWMP degeneration can be assessed in vivo using magnetic resonance imaging (MRI) proxies, but neuropathological validation is limited. METHODS We studied post mortem in situ 3T MRIs of 55 brain donors with standardized neuropathologic assessment (AD, LBD, AD+LBD, other dementias, controls). CWMP integrity was assessed quantitatively using diffusion tensor imaging and visually using the Cholinergic Pathways Hyperintensities Scale (CHIPS) on fluid‐attenuated inversion recovery MRI. RESULTS CWMP diffusivity was strongly associated with CHIPS ( p < 0.001 ), independent of global white matter damage. AD and AD+LBD showed greater CWMP degeneration than LBD, other dementias, and controls ( p < 0.05). Multivariate analyses across neuropathological variables identified hippocampal sclerosis and vascular co‐pathology as strongest predictors for CWMP degeneration. DISCUSSION CWMP degeneration is pronounced in AD and mixed AD+LBD pathology and is additionally affected by vascular co‐pathology and hippocampal sclerosis. CHIPS may serve as a clinically accessible MRI‐based proxy of CWMP integrity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Reina Sofia Alzheimer Center, CIEN Foundation, ISCIII, Madrid, Spain.
- Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
- Department of Cognitive Systems and Neurosciences, Czech Institute of Informatics, Robotics and Cybernetics, Czech Technical University in Prague, Prague, Czech Republic.
- Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- Department of Anatomy and Neurosciences, Amsterdam UMC, Amsterdam, the Netherlands.
- Program Neurodegeneration and Brain Imaging, Amsterdam Neuroscience, Amsterdam, the Netherlands.
Förderung
- Next Generation funding UE/Mecanismo de Recuperación y Resiliencia
- ISCIII
- European Union's Horizon Europe research and innovation programme
- Czech Science Foundation
- Swedish Research Council
- Center for Innovative Medicine
- regional agreement on medical training and clinical research of Stockholm Region
- Swedish Brain Foundation
Zitieren
APA
López-González, F. J., Nemy, M., Jerele, C., Jiménez-Pérez, A., López-Martínez, M. J., Jonkman, L., Rábano, A., Sánchez-Juan, P., Grothe, M. J., & Ferreira, D. (2026). Post mortem MRI of cholinergic white matter pathways across neurodegenerative diseases. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71851
Vancouver
López-González FJ, Nemy M, Jerele C, Jiménez-Pérez A, López-Martínez MJ, Jonkman L, et al. Post mortem MRI of cholinergic white matter pathways across neurodegenerative diseases. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71851
BibTeX
@article{LpezGonzlez2026,
author = {López-González, Francisco J and Nemy, Milan and Jerele, Cene and Jiménez-Pérez, Andrés and López-Martínez, María José and Jonkman, Laura and Rábano, Alberto and Sánchez-Juan, Pascual and Grothe, Michel J and Ferreira, Daniel},
title = {Post mortem MRI of cholinergic white matter pathways across neurodegenerative diseases},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71851}
}
EUVIMED